Kalofonos Isabel
All 5 shown
- CG Oncology, Inc. Chief commercial officer92,000 sharesGrant
- Crinetics Pharmaceuticals, Inc. Chief commercial officer$2,266,550Returned to the issuer
- Crinetics Pharmaceuticals, Inc. Chief commercial officer$4,329,975Returned to the issuer
- Crinetics Pharmaceuticals, Inc. Chief commercial officer$2,890,000Returned to the issuer
- Crinetics Pharmaceuticals, Inc. Chief commercial officer$141,865Returned to the issuer